Abstract
Stiff-person spectrum disorders (SPSD) are autoimmune disorders. Glutamic acid decarboxylase (GAD) is an intracellular presynaptic antigen which belongs to a unique category, different from onconeuronal antigens and postsynaptic proteins. However, the pathophysiology and the roles of anti-GAD65 antibodies remain unclear. Controversies regarding anti-GAD65 antibodies include whether the pathophysiology is mainly antibody- or T-cell-mediated and whether the antibodies have direct pathogenic role or just represent a biomarker. Current knowledge gaps also include interaction between anti-GAD65 antibodies and intracellular GAD65 antigen, as well as immunopathogenesis of other less common antibodies associated with SPSD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lancaster E, Dalmau J. Neuronal autoantigens–pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 2012;8(7):380–90. https://doi.org/10.1038/nrneurol.2012.99.
Abbas AK, Lichtman AH, Pillai S. Immunologic tolerance and autoimmunity. In: Abbas AK, Lichtman AH, Pillai S, editors. Cellular and molecular immunology. 9th ed. Philadelphia: Elsevier; 2018. p. 325–50.
Pugliese A, Solimena M, Awdeh ZL, Alper CA, Bugawan T, Erlich HA, et al. Association of HLA-DQB1∗0201 with stiff-man syndrome. J Clin Endocrinol Metab. 1993;77(6):1550–3. https://doi.org/10.1210/jcem.77.6.8263140.
Dalakas MC, Fujii M, Li M, McElroy B. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology. 2000;55(10):1531–5. https://doi.org/10.1212/wnl.55.10.1531.
Hiemstra HS, Schloot NC, van Veelen PA, Willemen SJ, Franken KL, van Rood JJ, et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A. 2001;98(7):3988–91. https://doi.org/10.1073/pnas.071050898.
Hassin-Baer S, Kirson ED, Shulman L, Buchman AS, Bin H, Hindiyeh M, et al. Stiff-person syndrome following West Nile fever. Arch Neurol. 2004;61(6):938–41. https://doi.org/10.1001/archneur.61.6.938.
Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest. 1994;94(5):2125–9. https://doi.org/10.1172/JCI117567.
Hyoty H. Enterovirus infections and type 1 diabetes. Ann Med. 2002;34(3):138–47.
Tong JC, Myers MA, Mackay IR, Zimmet PZ, Rowley MJ. The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera. Ann N Y Acad Sci. 2002;958:182–9. https://doi.org/10.1111/j.1749-6632.2002.tb02966.x.
Filippi CM, von Herrath MG. Viral trigger for type 1 diabetes: pros and cons. Diabetes. 2008;57(11):2863–71. https://doi.org/10.2337/db07-1023.
Lohmann T, Hawa M, Leslie RD, Lane R, Picard J, Londei M. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. Lancet. 2000;356(9223):31–5. https://doi.org/10.1016/S0140-6736(00)02431-4.
Lohmann T, Londei M, Hawa M, Leslie RD. Humoral and cellular autoimmune responses in stiff person syndrome. Ann N Y Acad Sci. 2003;998:215–22. https://doi.org/10.1196/annals.1254.024.
Baizabal-Carvallo JF, Jankovic J. Stiff-person syndrome: insights into a complex autoimmune disorder. J Neurol Neurosurg Psychiatry. 2015;86(8):840–8. https://doi.org/10.1136/jnnp-2014-309201.
Burton AR, Baquet Z, Eisenbarth GS, Tisch R, Smeyne R, Workman CJ, et al. Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells. J Immunol. 2010;184(9):4863–70. https://doi.org/10.4049/jimmunol.0903728.
Skorstad G, Hestvik AL, Vartdal F, Holmoy T. Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome. J Autoimmun. 2009;32(1):24–32. https://doi.org/10.1016/j.jaut.2008.10.002.
Skorstad G, Hestvik AL, Torjesen P, Alvik K, Vartdal F, Vandvik B, et al. GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence. Eur J Neurol. 2008;15(9):973–80. https://doi.org/10.1111/j.1468-1331.2008.02221.x.
Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW. Chronic thyroiditis and autoimmunization. J Am Med Assoc. 1957;164(13):1439–47. https://doi.org/10.1001/jama.1957.02980130015004.
Walikonis JE, Lennon VA. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc. 1998;73(12):1161–6. https://doi.org/10.4065/73.12.1161.
Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol. 2007;61(6):544–51. https://doi.org/10.1002/ana.21123.
Nemni R, Caniatti LM, Gironi M, Bazzigaluppi E, De Grandis D. Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies. Neurology. 2004;62(11):2101–2. https://doi.org/10.1212/01.wnl.0000127446.61806.2f.
Chang T, Alexopoulos H, Pettingill P, McMenamin M, Deacon R, Erdelyi F, et al. Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss. PLoS One. 2013;8(9):e72921. https://doi.org/10.1371/journal.pone.0072921.
Rakocevic G, Alexopoulos H, Dalakas MC. Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder. BMC Neurol. 2019;19(1):1. https://doi.org/10.1186/s12883-018-1232-z.
Irani SR. ‘Moonlighting’ surface antigens: a paradigm for autoantibody pathogenicity in neurology? Brain. 2016;139(Pt 2):304–6. https://doi.org/10.1093/brain/awv364.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Termsarasab, P., Thammongkolchai, T., Katirji, B. (2020). Immunopathogenesis of Stiff-Person Spectrum Disorders. In: Stiff-Person Syndrome and Related Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-43059-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-43059-7_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-43058-0
Online ISBN: 978-3-030-43059-7
eBook Packages: MedicineMedicine (R0)